Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Ooma
OOMA
$598M
| $841K | ﹤0.01% |
51,002
+1,407
| +3% | +$17.6K |
|
|
CASI
2677
DELISTED
CASI Pharmaceuticals
CASI
| $837K | ﹤0.01% |
33,480
+2,991
| +10% | +$65K |
|
|
MTEM
2678
DELISTED
Molecular Templates, Inc.
MTEM
| $837K | ﹤0.01% |
4,043
+618
| +18% | +$144K |
|
2679
Heritage Insurance Holdings
HRTG
$889M
| $835K | ﹤0.01% |
63,757
-2,997
| -4% | -$35.1K |
|
2680
Digi International
DGII
$2.63B
| $834K | ﹤0.01% |
71,559
+1,782
| +3% | +$19K |
|
2681
Cytosorbents Corp
CTSO
$22.7M
| $833K | ﹤0.01% |
84,080
+2,899
| +4% | +$26.6K |
|
|
CURO
2682
DELISTED
CURO Group Holdings Corp.
CURO
| $830K | ﹤0.01% |
101,585
+12,003
| +13% | +$85.4K |
|
2683
HBT Financial
HBT
$1.3B
| $829K | ﹤0.01% |
62,179
+5,298
| +9% | +$63.5K |
|
|
CASA
2684
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $825K | ﹤0.01% |
198,242
+16,590
| +9% | +$70.1K |
|
|
TELL
2685
DELISTED
Tellurian Inc.
TELL
| $823K | ﹤0.01% |
715,404
+139,423
| +24% | +$176K |
|
2686
Vitamin Cottage Natural Grocers
NGVC
$739M
| $821K | ﹤0.01% |
55,144
-15,537
| -22% | -$189K |
|
|
ORC
2687
Orchid Island Capital
ORC
$1.3B
| $821K | ﹤0.01% |
34,857
+350
| +1% | +$6.98K |
|
2688
Miller Industries
MLR
$573M
| $814K | ﹤0.01% |
27,321
| – | – |
|
|
STR
2689
DELISTED
Sitio Royalties
STR
| $814K | ﹤0.01% |
63,555
+3,939
| +7% | +$41.4K |
|
2690
Metropolitan Bank Holding Corp
MCB
$1.15B
| $809K | ﹤0.01% |
25,200
+735
| +3% | +$19.5K |
|
2691
IES Holdings
IESC
$14.8B
| $802K | ﹤0.01% |
34,597
+12,376
| +56% | +$259K |
|
2692
HF Foods Group
HFFG
$80.2M
| $795K | ﹤0.01% |
87,755
+30,081
| +52% | +$219K |
|
2693
UFP Technologies
UFPT
$1.97B
| $793K | ﹤0.01% |
17,997
+548
| +3% | +$23.4K |
|
2694
Graham Corp
GHM
$1.12B
| $792K | ﹤0.01% |
62,108
+5,276
| +9% | +$64.5K |
|
|
OSG
2695
DELISTED
Overseas Shipholding Group Inc.
OSG
| $790K | ﹤0.01% |
424,353
+24,082
| +6% | +$53.4K |
|
|
BCOV
2696
DELISTED
Brightcove, Inc.
BCOV
| $789K | ﹤0.01% |
100,021
+224
| +0.2% | +$1.8K |
|
2697
Daily Journal
DJCO
$809M
| $785K | ﹤0.01% |
2,907
+86
| +3% | +$22.9K |
|
|
JCAP
2698
DELISTED
Jernigan Capital, Inc.
JCAP
| $784K | ﹤0.01% |
57,304
+1,413
| +3% | +$18.2K |
|
2699
Artesian Resources
ARTNA
$355M
| $772K | ﹤0.01% |
21,259
+31
| +0.1% | +$1.09K |
|
|
BCLI
2700
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $772K | ﹤0.01% |
4,585
+3,833
| +510% | +$413K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.